Five Industry Leaders Join Vori Health

Vori Health, an all-inclusive medical provider for musculoskeletal (MSK) care, announces the addition of five executives to its senior leadership team. These new executives join to fortify and scale the 18-month-old company’s inclusive mission to improve access to improved evidence-based care. Through clinical excellence care teams, behavioral integration, and technology, Vori Health creates a community of care to navigate best practices and improve outcomes.

The new executive team members joined Vori Health in the last three months, and all report to Co-founder and CEO, Ryan Grant, MD: They include:

Cindy Nguyen, Chief Financial Officer

David Deane, Chief Commercial Officer

Akshara Reddy, Chief Strategy Officer

Nadian Zak, Chief People Officer

Deborah Conrad, Chief Marketing Officer

“We are at an inflection point at Vori Health requiring the investment in top talent to lead the company during this growth and scale phase,” said Dr. Grant. “We have a tremendous opportunity to improve the care for people who suffer from back, neck, hip, and knee pain and related issues, which is the number one cause of disability across the world. The addition of these industry leaders will allow us to ramp our products and services to reach more people and provide outstanding care.”

Vori Health recently closed its Series A (~$68mm) funding led by New Enterprise Associates, Inc. (NEA), along with participation from AlleyCorp, Intermountain Health, Ascension Ventures, Echo Health Ventures, Max Ventures, and Pacific Western Bank.

The company will roll-out all of its services nationwide by mid-2022. People can access Vori Health’s services directly, or as a benefit provided by their employer, or referred to by their primary care physicians and other specialty care providers.

“Each of these leaders has a proven track record in their area of expertise and a shared passion to create a new kind of health care experience that benefits our patients,” said Co-Founder and Chief Medical Officer, Dr. Mary O’Connor. “We have important work to do to make healthcare better for all, and this team will take us to the next level to ensure our patients are getting outstanding care, in the most efficient and effective way,” she added.

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."